251 related articles for article (PubMed ID: 4609432)
1. The UGDP--tolbutamide and mortality.
Knowles HC
Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
[No Abstract] [Full Text] [Related]
2. Comments on the UGDP study.
Schöffling K
Horm Metab Res; 1974; Suppl 4():188-91. PubMed ID: 4608018
[No Abstract] [Full Text] [Related]
3. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report.
Diabetes; 1982 Nov; 31 Suppl 5():1-81. PubMed ID: 6757026
[No Abstract] [Full Text] [Related]
4. A progress report on the University Group Diabetes Program.
Prout TE
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):244-51. PubMed ID: 809369
[TBL] [Abstract][Full Text] [Related]
5. The UGDP study.
Salsburg DS
JAMA; 1971 Dec; 218(11):1704-5. PubMed ID: 4940315
[No Abstract] [Full Text] [Related]
6. Phenformin and vascular complications of diabetes.
Med Lett Drugs Ther; 1972 Jan; 14(1):1-2. PubMed ID: 4567560
[No Abstract] [Full Text] [Related]
7. [The venture of University Group Diabetes Program (UGDP). Some personal reflexions. Tolbutamide and phenformin under accusation].
Pirart J
Nouv Presse Med; 1972 Jan; 1(5):325-8. PubMed ID: 5010448
[No Abstract] [Full Text] [Related]
8. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB
JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344
[No Abstract] [Full Text] [Related]
9. Editorial: Oral hypoglycemic drugs.
Scoville AB
J Tenn Med Assoc; 1975 Apr; 68(4):319-20. PubMed ID: 1117723
[No Abstract] [Full Text] [Related]
10. The controversial American University Group Diabetes Study--a look at sulfonylurea and biguanide therapy.
Kilo C; Williamson JR
Horm Metab Res Suppl; 1985; 15():102-4. PubMed ID: 3908276
[No Abstract] [Full Text] [Related]
11. [Considerations on diabetic angiopathies. Relations to hypoglycemic treatments].
Lubetzki J
Nouv Presse Med; 1972 Mar; 1(11):715-8. PubMed ID: 5022249
[No Abstract] [Full Text] [Related]
12. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
Polosa P; Mughini L
Minerva Med; 1974 Aug; 65(59):383-9. PubMed ID: 4213556
[No Abstract] [Full Text] [Related]
13. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
Tattersall RB
Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
[No Abstract] [Full Text] [Related]
14. An historical view of the medical-social aspects of the UGDP.
Knowles HC
Trans Am Clin Climatol Assoc; 1977; 88():150-6. PubMed ID: 898533
[No Abstract] [Full Text] [Related]
15. A prospective view of the treatment of adult-onset diabetes with special reference to the University Group Diabetes Program and oral hypoglycemic agents.
Prout TE
Med Clin North Am; 1971 Jul; 55(4):1065-75. PubMed ID: 4946757
[No Abstract] [Full Text] [Related]
16. The influence of diagnostic criteria on the mortality findings in the University Group Diabetic Programme study of diabetic therapy.
Gray RH
Med J Aust; 1973 Mar; 1(12):594-6. PubMed ID: 4573383
[No Abstract] [Full Text] [Related]
17. The UGDP controversy. Clinical trials versus clinical impressions.
Prout TE; Knatterud GL; Meinert CL; Klimt CR
Diabetes; 1972 Oct; 21(10):1035-40. PubMed ID: 4561330
[No Abstract] [Full Text] [Related]
18. [Causes of death in diabetes mellitus].
Akhmetzianov AM; Mazovetskiĭ AG; Kliachko VR
Probl Endokrinol (Mosk); 1975; 21(1):103-11. PubMed ID: 1094446
[No Abstract] [Full Text] [Related]
19. [Clinical testing of Tolbutaphen in the treatment of adult diabetes].
Schneider J; Kaffarnik H
Z Allgemeinmed; 1975 Jan; 51(2):74-5. PubMed ID: 766424
[No Abstract] [Full Text] [Related]
20. The crux of the UGDP. Spurious results and biologically inappropriate data analysis.
Kilo C; Miller JP; Williamson JR
Diabetologia; 1980 Mar; 18(3):179-85. PubMed ID: 6989693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
